ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Treatment of Acute Myeloid Leukemia Clinical data showing ...

MUSC researchers at the Hollings Cancer center are making strides in new developments for leukemia treatment.Sophie Paczesny, ...

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...

Panelists highlight that patient advocacy is crucial in improving high-risk acute myeloid leukemia (AML) outcomes by ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

A watercolor set gifted during my bone marrow transplant for acute myeloid leukemia became my outlet for wonder, creativity, ...

The therapy achieved an overall response rate of 33%, exceeding the 20% threshold, with some patient groups achieving 50% ...

Scientists at Indiana University School of Medicine have identified a new approach that could transform treatment for acute ...

Bleeding gums need not always be associated with leukaemia however frequent bleeding in gums may be a sign of something more ...

New research has found that millions of children are at increased risk of exposure to cancer-causing chemicals ...

Researchers at MUSC Hollings Cancer Center have identified a signaling loop involved in the growth and persistence of ...

SELLAS Life Sciences (SLS) stock gains as a Phase 2 trial for its cancer drug SLS009 succeds in patients with acute myeloid ...